Publications scientifiques

Depuis le 27/04/2022

  1. De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring.
    Moulis G, Crickx E, Thomas L, Massy N, Mahévas M, Valnet-Rabier MB, Atzenhoffer M, Michel M, Godeau B, Bagheri H, Salvo F; and the French Covigilance COVID-19 Vaccine-ITP Study Group.
    Blood. 2022
  2. The Multidimensional Nature of Research Ethics: Letters Issued by a French Research Ethics Committee Included Similar Proportions of Ethical and Scientific Queries.
    Haaser T, Bouteloup V, Berdaï D, Saux MC.
    J Empir Res Hum Res Ethics. 2022
  3. Asthmatic bronchial smooth muscle increases rhinovirus replication within the bronchial epithelium.
    Esteves P, Allard B, Celle A, Dupin I, Maurat E, Ousova O, Thumerel M, Dupuy JW, Leste-Lasserre T, Marthan R, Girodet PO, Trian T, Berger P.
    Cell Rep. 2022
  4. Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control study.
    Bénard-Laribière A, Hucteau E, Debette S, Kirchgesner J, Bezin J, Pariente A.
    BMJ. 2022
  5. Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
    Duvignaud A, Lhomme E, Onaisi R, Sitta R, Gelley A, Chastang J, Piroth L, Binquet C, Dupouy J, Makinson A, Lefèvre B, Naccache JM, Roussillon C, Landman R, Wallet C, Karcher S, Journot V, Nguyen D, Pistone T, Bouchet S, Lafon ME, Molimard M, Thiébaut R, de Lamballerie X, Joseph JP, Richert L, Saint-Lary O, Djabarouti S, Wittkop L, Anglaret X, Malvy D; Coverage Study Group; SA1-1: Members of the COVERAGE France Study Group. Sponsor (CHU Bordeaux); National Trial Coordination Unit: CIC-EC 1401/EUCLID; MEREVA; National Coordinating Pharmacy; National Coordinating Laboratories; Bordeaux; Créteil; Bordeaux Study center; Investigating physicians; Coordination; Dijon Study center; Investigating physicians; Coordination; Nancy Study center: Investigating physicians; Coordination; Toulouse Study sites; Investigating physicians; Coordination; Bastia Study center; Investigating physicians; Coordination; Montpellier Study center: Investigating physicians; Coordination; Paris Study center 1: Collège National des Généralistes Enseignants (CNGE); Investigating physicians; Coordination; Paris Study center 2; Groupe Hospitalier Paris Saint Joseph (GHPSJ); Investigating physicians; Coordination; Paris Study center 3: Institut de Médecine et d’Epidémiologie Appliquée (IMEA); Coordination; Nantes/Angers Study center; Investigating physicians; Coordination; Others contributors; Scientific Advisory Board: Voting members; Non-voting members; Data Safety Monitoring Board.
    Clin Microbiol Infect. 2022
  6. Emergency room admissions induced by drug-drug interactions in the elderly: a cross-sectional study.
    Letinier L, Pujade I, Duthoit P, Evrard G, Salvo F, Gil-Jardine C, Pariente A.
    Clin Transl Sci. 2022
  7. Psychoactive substance use among students: a cross-sectional analysis.
    Perino J, Tournier M, Mathieu C, Letinier L, Peyré A, Perret G, Peirera E, Fourrier-Réglat A, Pollet C, Fatseas M, Tzourio C, Daveluy A.
    Fundam Clin Pharmacol. 2022
  8. High-Dimensional Propensity Score-Adjusted Case-Crossover for Discovering Adverse Drug Reactions from Computerized Administrative Healthcare Databases.
    Volatier E, Salvo F, Pariente A, Courtois É, Escolano S, Tubert-Bitter P, Ahmed I.
    Drug Saf. 2022
  9. Conceiving, conducting, reporting, interpreting, and publishing disproportionality analyses: A call to action.
    Raschi E, Salvo F, Khouri C.
    Br J Clin Pharmacol. 2022
  10. Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273).
    Préta LH, Contejean A, Salvo F, Treluyer JM, Charlier C, Chouchana L.
    Br J Clin Pharmacol. 2022
  11. [Ketamine use in outpatients: What can we learn from current practices?]
    Salvati A, Daveluy A, Clavery R, Miremont-Salamé G, Micallef J, Frauger É; Réseau français d’addictovigilance.
    Therapie. 2022
  12. Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF).
    Greillier L, Gauvrit M, Paillaud E, Girard N, Montégut C, Boulahssass R, Wislez M, Pamoukdjian F, Corre R, Cabart M, Caillet P, Belaroussi Y, Frasca M, Noize P, Wang P, Mebarki S, Mathoulin-Pelissier S, Couderc AL.
    Cancers (Basel). 2022
  13. Methoxpropamine (MXPr) in powder, urine and hair samples: Analytical characterization and metabolite identification of a new threat.
    Goncalves R, Castaing N, Richeval C, Ducint D, Titier K, Morvan E, Grélard A, Loquet A, Molimard M.
    Forensic Sci Int. 2022
  14. Pharmacokinetics and therapeutic drug monitoring of anticancer protein/kinase inhibitors.
    Bouchet S, Molimard M.
    Therapie. 2021
  15. Prevention of risks associated with inappropriate use/unnecessary consumption of medicines.
    Cracowski JL, Muller S, Anglade I, Bonnefond G, Bouhanick B, Bouquet S, Cabut S, Daynès P, Denis B, Durand D, Jonville-Béra AP, Lahouegue A, Léo M, Micallef J, Molimard M, Penfornis C, Querol-Ferrer V.
    Therapie. 2022
  16. Prévention des risques liés à un usage inapproprié/consommation inutile des médicaments.
    Cracowski JL, Muller S, Anglade I, Bonnefond G, Bouhanick B, Bouquet S, Cabut S, Daynès P, Denis B, Durand D, Jonville-Béra AP, Lahouegue A, Léo M, Micallef J, Molimard M, Penfornis C, Querol-Ferrer V.
    Therapie. 2022
  17. Antiherpetic drugs: a potential way to prevent Alzheimer's disease?
    Linard M, Bezin J, Hucteau E, Joly P, Garrigue I, Dartigues JF, Pariente A, Helmer C.
    Alzheimers Res Ther. 2022
  18. Antihypertensive and lipid-lowering drugs usage after primary stroke in a large representative sample of the French population.
    Perrier J, Olié V, Gabet A, Tzourio C, Bezin J.
    Fundam Clin Pharmacol. 2022
  19. Spontaneous reporting of adverse-drug reactions as an outlet for patient dismay? The case of Levothyrox® change of excipients.
    Romani S, Fresse A, Parassol-Girard N, Gerard A, Levraut M, Yamani S, Van Obberghen E, Pariente A, Rocher F, Viard D, Drici MD.
    Fundam Clin Pharmacol. 2022
  20. Pharmacoepidemiology for oncology clinical practice: Foundations, state of the art and perspectives.
    de Germay S, Berdaï D, Noize P.
    Therapie. 2021